-
Mashup Score: 0New Report Reviews Methods for Reducing Waste, Improving Efficiency With Expensive Injectable Medications - The ASCO Post - 3 year(s) ago
By The ASCO Post Staff Posted: 2/26/2021 10:00:00 AM Last Updated: 2/26/2021 4:12:52 PM Every year, significant amounts of drugs left over and unused from single-dose vials are discarded, but because of the way drugs are priced and paid for in the United States, the cost of…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Biden Makes Good on Two Early Promises - 3 year(s) ago
Rescinds ‘Mexico City Policy,’ directs HHS to allow special Obamacare enrollment period
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
President Biden directed his administration to reverse these #healthcare related actions by the Trump administration. By @joycefr, @MedPagePolicy. @JoeBiden #healthcarepolicy https://t.co/8tthjkS9EO
-
-
Mashup Score: 3Medicaid Expansion May Be Linked to Lower Mortality Rates for Three Major Types of Cancer - The ASCO Post - 3 year(s) ago
In states that have expanded Medicaid availability as part of the Affordable Care Act (ACA), mortality rates for three major types of cancer are significantly lower than in states that have not expanded Medicaid availability, according to a recent study by researchers at Dana-Farber Cancer Institute, Brigham and Women’s…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Medicaid Expansion May Be Linked to Lower Mortality Rates for Three Major Types of #Cancer https://t.co/pFFT42DlTP #healthcarepolicy
-
-
Mashup Score: 0Pay-for-Performance Program to Reimburse Oncology Practices for Prescribing Evidence-Based Cancer Drugs - The ASCO Post - 4 year(s) ago
A pay-for-performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based cancer drugs increased use of these drugs without significantly changing total spending on care, Penn Medicine researchers reported in a study published in the Journal of Clinical Oncology.1…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Pay-for-Performance Program to Reimburse #Oncology Practices for Prescribing Evidence-Based #Cancer Drugs https://t.co/IN3atUK9rE #healthcarepolicy
-
-
Mashup Score: 0ACA, Pandemic Take Center Stage at Unruly Presidential Debate - 4 year(s) ago
In chaotic debate, Trump and Biden clash over Obamacare and COVID-19
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The first presidential debate between @realDonaldTrump and @JoeBiden touched on numerous issues in healthcare. By @shannonfirth, @MedPageID. #Election2020 #healthcarepolicy #publicpolicy #medtwitter #medstudenttwitter https://t.co/WOkrK8OahP
-
-
Mashup Score: 0Impact of Prior Insurance Coverage Disruptions on Health-Care Access and Affordability for Currently Insured Cancer Survivors - The ASCO Post - 4 year(s) ago
By The ASCO Post Staff Posted: 9/1/2020 12:38:00 PM Last Updated: 9/2/2020 1:36:34 PM A new study from the American Cancer Society has found health insurance coverage disruptions in the prior year led to issues with health-care access and affordability for currently insured…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Impact of Prior Insurance Coverage Disruptions on Health-Care Access and Affordability for Currently Insured Cancer Survivors https://t.co/k2d8FHO96w #oncology #cancer #survivorship #healthcarepolicy
-
-
Mashup Score: 2Past CMS and FDA Head Discusses Challenges in U.S. Health-Care Policy and Possible Solutions - The ASCO Post - 4 year(s) ago
A Conversation With Mark McClellan, MD, PhD Mark McClellan, MD, PhD As evidenced at this year’s ASCO20 Virtual Scientific Program, oncology science, technology, and clinical practice are evolving at a rapid pace, bringing new challenges to the efficient and ethical practice of cancer care at all levels. To shed light on…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Past CMS and FDA Head Discusses Challenges in U.S. Health-Care Policy and Possible Solutions: A Conversation With Mark McClellan, MD, PhD https://t.co/Jx7STnpvis #healthcarepolicy #costofcare #oncology https://t.co/oa4aLO5JYZ
-
-
Mashup Score: 0
Earlier this month, health care policy suddenly managed to steal some headlines away from impeachment and the ongoing horserace of the 2020 Democratic presidential primary, when President Donald Trump declared in a tweet that he, “was the person who saved” protections for patients with preexisting conditions.That Jan. 13 statement — a response to a television ad in which
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
From @HealioRheum: Trump’s claim to have ‘saved’ preexisting conditions clashes with record #healthcarepolicy https://t.co/OQ3FjHuO1A
-
-
Mashup Score: 0
Earlier this month, health care policy suddenly managed to steal some headlines away from impeachment and the ongoing horserace of the 2020 Democratic presidential primary, when President Donald Trump declared in a tweet that he, “was the person who saved” protections for patients with preexisting conditions.That Jan. 13 statement — a response to a television ad in which
Source: www.healio.comCategories: Latest Headlines, PulmonologyTweet-
Feature from @HealioRheum: Trump’s claim to have ‘saved’ preexisting conditions clashes with record #healthcarepolicy https://t.co/kPis9EKy2j
-
-
Mashup Score: 2Physicians, New Drugs, and Pharma - The ASCO Post - 4 year(s) ago
By Robert Peter Gale, MD, PhD, DSc (hc), FACP, FRCPI (hon), FRSM, and Hillard M. Lazarus, MD, FACP August 10, 2020 The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) have approved record numbers of new cancer drugs recently. This is extraordinarily good news for…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Dr. Robert Peter Gale & Dr. Hillard M. Lazarus on Physicians, New Drugs, and Pharma https://t.co/9arnHf0lYz #costofcare #healthcarepolicy https://t.co/BnnyJLhU5X
-
New Report Reviews Methods for Reducing Waste, Improving Efficiency With Expensive Injectable Medications https://t.co/0UWpfnypZ5 #oncology #healthcarepolicy